Harnessing cellular immunotherapy for cholangiocarcinoma: an integrated roadmap for overcoming resistance
Saied Froghi, Astero Klampatsa, Brian Davidson · 2026
Read Harnessing cellular immunotherapy for cholangiocarcinoma: an integrated roadmap for overcoming resistance by Saied Froghi, Astero Klampatsa, Brian Davidson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194377.txt.
Description
Saied Froghi and co-authors review in 2026 how cell based immune therapy might be made to work for cholangiocarcinoma, a bile duct cancer with rising rates and a poor outlook. Engineered CAR cell therapies have changed care for some cancers, yet this tumor blocks them with dense tissue, a suppressive local setting, and wide variation in targets across tumor cells.
The review compares key tumor targets, weighing how often each appears and what lab and clinical results show so far. It breaks resistance into physical, immune, and metabolic barriers, then maps each to design fixes. Pairing CAR cells with checkpoint drugs or natural immune compounds is also weighed. The authors call for trials guided by biomarkers and close with a four part roadmap for the field.
Catalog record
| CREATOR | Saied Froghi, Astero Klampatsa, Brian Davidson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |